Abstract

Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain. Two prevalent models of SYK activation exist. The "OR-gate" model contends that SYK can be fully activated by phosphorylation or binding of its SH2 domains to a dual-phosphorylated immune-receptor tyrosine-based activation motif (ppITAM). An alternative model proposes that SYK activation requires ppITAM binding and phosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family tyrosine kinase (LYN). To evaluate these two models, we generated directly comparable unphosphorylated (upSYK) and phosphorylated (pSYK) proteins with or without an N-terminal glutathione S-transferase (GST) tag, resulting in monomeric or obligatory dimeric SYK, respectively. We assessed the ability of a ppITAM peptide and LYN to activate these SYK proteins. The ppITAM peptide strongly activated GST-SYK but was less effective in activating upSYK untagged with GST. LYN alone activated untagged upSYK to a greater extent than did ppITAM, and inclusion of both proteins rapidly and fully activated upSYK. Using immunoblot and phosphoproteomic approaches, we correlated the kinetics and order of site-specific SYK phosphorylation. Our results are consistent with the alternative model, indicating that ppITAM binding primes SYK for rapid LYN-mediated phosphorylation of Tyr-352 and then Tyr-348 of the SH2-kinase linker, which facilitates activation loop phosphorylation and full SYK activation. This gradual activation mechanism may also explain how SYK maintains ligand-independent tonic signaling, important for B-cell development and survival.

Highlights

  • Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain

  • glutathione S-transferase (GST)-upSYK and nontagged upSYK were prepared in a manner to maintain the lowest levels of phosphorylation, whereas GST-pSYK and nontagged pSYK were prepared to obtain the highest levels of total SYK phosphorylation achievable under in vitro conditions

  • The differential levels of phosphorylation of both nontagged and GST-tagged (GST-pSYK versus GST-upSYK) SYK were confirmed by Western blot analysis (Fig. 2A)

Read more

Summary

ARTICLE cro

SYK can be autophosphorylated or phosphorylated by SRC family kinases at multiple nonequivalent phosphorylation sites across various domains of the protein, but it is responsive to binding of ppITAM sequences in the cytoplasmic domain of immune receptor-associated proteins. This complex activation process may allow SYK to mediate both high (i.e. immune ligand) and low (i.e. tonic) level signaling and provide additional opportunities for pharmacological intervention beyond just ATP-competitive.

SYK activation mechanism
Characterization of recombinant SYK enzymes
SYK phosphospecific analysis using mass spectrometry
NDb ND
Cloning and expression of all SYK isoforms
Purification of all SYK isoforms
Omnia assay
Kinase assay and Western blot analysis
Mass spectrometry analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call